Updated Financial Calendar for 2022

29.03.2022 - Orphazyme A/S in restructuringCompany announcementNo. 14/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 29, 2022 – Orphazyme A/S in restructuring (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a late-stage ...

Related Keywords

Denmark ,Copenhagen ,Køavn ,Switzerland ,Danish ,John Sommer Schmidt ,Anders Vadsholt ,Company Financial Calendar ,Danish Business Authority ,Exchange Commission ,European Medicines Agency ,Drug Administration ,Committee For Medicinal Products Human Use ,Danish Financial Supervisory Authority ,Financial Calendar ,Business Authority ,Danish Financial Statements ,Annual General ,Annual General Meeting ,General Meeting ,Report First Half ,Chief Executive Officer ,Chief Financial Officer ,Sommer Schmidt ,Restructuring Administrator ,Nasdaq Copenhagen ,Orphan Drug Designation ,Fast Track Designation ,Breakthrough Therapy Designation ,Rare Pediatric Disease Designation ,Complete Response Letter ,New Drug ,Typec Meeting ,Medicinal Products ,Human Use ,Trend Vote ,Marketing Authorization Application ,